A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California

NCT07332312 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2026-05-11

No results posted yet for this study

Summary

This clinical trial develops and tests whether a culturally informed patient navigation program, Community-Focused Patient Navigation (CFPN), works to reduce delays between diagnosis and treatment in American Indian and Alaska Native (AIAN) cancer patients living in rural California. AIAN communities face some of the most severe cancer disparities in the United States, including higher death rates, later-stage diagnoses, and limited access to timely, culturally responsive care. This may be due to barriers such as rural isolation, divided referral systems, or a lack of trust in mainstream healthcare systems. Patient navigation is a care delivery model designed to guide a patient through the healthcare system and address the barriers that prevent patients from accessing timely and effective care. The CFPN program is culturally tailored and designed with AIAN communities in mind. The program provides the patient with a treatment plan based on the patient's unique needs, goals, and barriers. This may be an effective way to reduce delays between diagnosis and treatment in AIAN cancer patients living in rural California.

Conditions

  • Hematopoietic and Lymphatic System Neoplasm
  • Malignant Solid Neoplasm

Interventions

OTHER

Electronic Health Record Review

Ancillary studies

OTHER

Interview

Complete KII

OTHER

Interview

Ancillary studies

BEHAVIORAL

Patient Navigation

Engage with CFPN program navigator

OTHER

Survey Administration

Ancillary studies

PROCEDURE

Tailored Intervention

Receive treatment plan

OTHER

Discussion

Complete focus group

OTHER

Educational Intervention

Receive opioid misuse education and care coordination

OTHER

Discussion

Serve on CAB

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • American Cancer Society, Inc.

    collaborator OTHER
  • Pfizer

    collaborator INDUSTRY
  • University of Southern California

    lead OTHER

Principal Investigators

  • Claradina Soto · University of Southern California

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-17
Primary Completion
2027-11-13
Completion
2028-11-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07332312 on ClinicalTrials.gov